← All stocks

Coherus Oncology, Inc.

CHRS No buying or selling

CIK 0001512762 #3931 in the set updated 22 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

10 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Lanfear Dennis M

President & CEO

—

1,048,235

$774.54K

+47.9%

McMichael Bryan J

Chief Financial Officer

—

133,736

$98.82K

+407.1%

Reider Paul

Chief Commercial Officer

—

82,069

$60.64K

−10.1%

Satvat Ali J.

Director

—

30,000

$22.17K

—

Newton Charles W.

Director

—

30,000

$22.17K

—

Wahlstrom Mats

Director

—

30,000

$22.17K

−70.0%

Newcomer Lee Nisley

Director

—

30,000

$22.17K

—

Karachun Rita A

Director

—

30,000

$22.17K

—

Ryan Michael Lee

Director

—

30,000

$22.17K

—

O'Donnell-Tormey Jill

Director

—

30,000

$22.17K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 6 Sep 2016